Rfk mRNA expression has previously been demonstrated to be decreased in AD patients and the Aβ‐based yeast model.[10] However, in our study, we observed increased RFK protein expression in the cortex and hippocampus of the LPS‐induced mouse model and 5xFAD mouse model of AD. Here, RFK is linked to Alzheimer disease.